See the Complete Picture.
Published loading...Updated

Genprex Signs Sponsored Research Agreement with the University of Pittsburgh to Study Diabetes Gene Therapy in Type 1 and Type 2 Diabetes

Summary by Stemwell Science News
Genprex, Inc. announced that following the recent completion of its two-year Sponsored Research Agreement (SRA) with the University of Pittsburgh of the Commonwealth System of Higher Education to study T1D and T2D, the parties have entered into a new SRA to study GPX-002 in T1D and T2D in animal models. [Genprex, Inc. ] Press Release
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Stemwell Science News broke the news in on Tuesday, May 13, 2025.
Sources are mostly out of (0)